Compare $MBRX vs $SNGX | Chartloom

Compare

$MBRX vs $SNGX

Moleculin Biotech Inc · Soligenix Inc

MBRX

Moleculin Biotech Inc

SNGX

Soligenix Inc

Compare $MBRX vs $SNGX

Comparing Moleculin Biotech Inc and Soligenix Inc

MBRXMoleculin Biotech Inc

SNGXSoligenix Inc

MBRXMoleculin Biotech Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.8%

52W performance

-96.5%

FCF yield

-811.4%

SNGXSoligenix Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.4%

52W performance

-79.9%

FCF yield

-180.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MBRX

SNGX

Detailed metrics comparison

MBRX

Moleculin Biotech Inc

SNGX

Soligenix Inc

Market Cap

MBRX$3M

SNGX$5M

Enterprise Value

MBRX$-4M

SNGX$-4M

Price

MBRX$0.44

SNGX$0.36

P/E Ratio

MBRXN/A

SNGXN/A

P/S Ratio

MBRX0.00x

SNGX16.09x

EV/Sales

MBRX0.00x

SNGX-3.76x

EV/EBITDA

MBRX0.00x

SNGX-1.54x

P/B Ratio

MBRX0.86x

SNGX1.20x

P/FCF Ratio

MBRXN/A

SNGXN/A

EV/FCF

MBRX0.16x

SNGX0.45x

PEG Ratio

MBRXN/A

SNGXN/A

Forward P/E (NTM)

MBRXN/A

SNGXN/A

Forward P/S (NTM)

MBRXN/A

SNGXN/A

Revenue (TTM)

MBRX$0

SNGX$0

Revenue Growth (YoY)

MBRXN/A

SNGXN/A

Forward Rev Growth

MBRX131.1%

SNGX0.0%

Gross Margin (TTM)

MBRX0.0%

SNGX8.8%

Operating Margin (TTM)

MBRX0.0%

SNGX0.0%

EBITDA Margin (TTM)

MBRX0.0%

SNGX0.0%

Net Margin (TTM)

MBRX0.0%

SNGX0.0%

FCF Margin (TTM)

MBRXN/A

SNGXN/A

Net Income (TTM)

MBRX$-33M

SNGX$-10M

FCF (TTM)

MBRX$-25M

SNGX$-10M

EPS (TTM)

MBRX-$5.73

SNGX-$0.64

ROE (TTM)

MBRX-3539.0%

SNGX-18102.0%

ROA (TTM)

MBRX-13955.0%

SNGX-10792.0%

ROIC (TTM)

MBRX-3539.0%

SNGX-18102.0%

Cash

MBRX$7M

SNGX$10M

Debt

MBRX$0

SNGX$0

Net Cash/Debt

MBRX$7M

SNGX$10M

Current Ratio (TTM)

MBRX0.94x

SNGX2.77x

Quick Ratio (TTM)

MBRX0.78x

SNGX2.67x

Debt/Equity (TTM)

MBRX0.00x

SNGX0.00x

Debt/Assets (TTM)

MBRX0.0%

SNGX0.0%

Interest Coverage (TTM)

MBRXN/A

SNGXN/A

Net Debt/EBITDA (TTM)

MBRX0.00x

SNGX0.00x

Beta

MBRX2.10

SNGX2.15

52W Performance

MBRX-96.5%

SNGX-79.9%

YTD Performance

MBRX-87.8%

SNGX-74.4%

% from 52W High

MBRX-97.2%

SNGX-81.5%

% from 52W Low

MBRX173.9%

SNGX29.9%

Asset Turnover (TTM)

MBRX0.00x

SNGX0.05x

FCF Yield (TTM)

MBRX-811.4%

SNGX-180.8%

Earnings Yield (TTM)

MBRX-1040.8%

SNGX-190.0%

Dividend Yield (TTM)

MBRXN/A

SNGXN/A

Rule of 40

MBRX0.0

SNGX0.0

EV/GP/RG

MBRXN/A

SNGXN/A

Ticker research

View MBRX research View SNGX research

Metric	MBRX Moleculin Biotech Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$3M	$5M
Enterprise Value	$-4M	$-4M
Price	$0.44	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.09x
EV/Sales	0.00x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	0.86x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	131.1%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-10M
FCF (TTM)	$-25M	$-10M
EPS (TTM)	-$5.73	-$0.64
ROE (TTM)	-3539.0%	-18102.0%
ROA (TTM)	-13955.0%	-10792.0%
ROIC (TTM)	-3539.0%	-18102.0%
Financial Health
Cash	$7M	$10M
Debt	$0	$0
Net Cash/Debt	$7M	$10M
Current Ratio (TTM)	0.94x	2.77x
Quick Ratio (TTM)	0.78x	2.67x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.10	2.15
52W Performance	-96.5%	-79.9%
YTD Performance	-87.8%	-74.4%
% from 52W High	-97.2%	-81.5%
% from 52W Low	173.9%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-811.4%	-180.8%
Earnings Yield (TTM)	-1040.8%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MBRX research	View SNGX research

Valuation

P/S Ratio

MBRX

0.00x

SNGX

16.09x

EV/FCF

MBRX

0.16x

SNGX

0.45x

Growth & revenue

Forward Revenue Growth

MBRX

131.1%

SNGX

0.0%

Profitability & performance

Gross Margin

SNGX

8.8%

MBRX

0.0%

ROE

MBRX

-3539.0%

SNGX

-18102.0%

FCF Yield %

SNGX

-180.8%

MBRX

-811.4%

52-Week Performance

SNGX

-79.9%

MBRX

-96.5%

Detailed metrics comparison

MBRX

Moleculin Biotech Inc

SNGX

Soligenix Inc

Market Cap

MBRX$3M

SNGX$5M

Enterprise Value

MBRX$-4M

SNGX$-4M

Price

MBRX$0.44

SNGX$0.36

P/E Ratio

MBRXN/A

SNGXN/A

P/S Ratio

MBRX0.00x

SNGX16.09x

EV/Sales

MBRX0.00x

SNGX-3.76x

EV/EBITDA

MBRX0.00x

SNGX-1.54x

P/B Ratio

MBRX0.86x

SNGX1.20x

P/FCF Ratio

MBRXN/A

SNGXN/A

EV/FCF

MBRX0.16x

SNGX0.45x

PEG Ratio

MBRXN/A

SNGXN/A

Forward P/E (NTM)

MBRXN/A

SNGXN/A

Forward P/S (NTM)

MBRXN/A

SNGXN/A

Revenue (TTM)

MBRX$0

SNGX$0

Revenue Growth (YoY)

MBRXN/A

SNGXN/A

Forward Rev Growth

MBRX131.1%

SNGX0.0%

Gross Margin (TTM)

MBRX0.0%

SNGX8.8%

Operating Margin (TTM)

MBRX0.0%

SNGX0.0%

EBITDA Margin (TTM)

MBRX0.0%

SNGX0.0%

Net Margin (TTM)

MBRX0.0%

SNGX0.0%

FCF Margin (TTM)

MBRXN/A

SNGXN/A

Net Income (TTM)

MBRX$-33M

SNGX$-10M

FCF (TTM)

MBRX$-25M

SNGX$-10M

EPS (TTM)

MBRX-$5.73

SNGX-$0.64

ROE (TTM)

MBRX-3539.0%

SNGX-18102.0%

ROA (TTM)

MBRX-13955.0%

SNGX-10792.0%

ROIC (TTM)

MBRX-3539.0%

SNGX-18102.0%

Cash

MBRX$7M

SNGX$10M

Debt

MBRX$0

SNGX$0

Net Cash/Debt

MBRX$7M

SNGX$10M

Current Ratio (TTM)

MBRX0.94x

SNGX2.77x

Quick Ratio (TTM)

MBRX0.78x

SNGX2.67x

Debt/Equity (TTM)

MBRX0.00x

SNGX0.00x

Debt/Assets (TTM)

MBRX0.0%

SNGX0.0%

Interest Coverage (TTM)

MBRXN/A

SNGXN/A

Net Debt/EBITDA (TTM)

MBRX0.00x

SNGX0.00x

Beta

MBRX2.10

SNGX2.15

52W Performance

MBRX-96.5%

SNGX-79.9%

YTD Performance

MBRX-87.8%

SNGX-74.4%

% from 52W High

MBRX-97.2%

SNGX-81.5%

% from 52W Low

MBRX173.9%

SNGX29.9%

Asset Turnover (TTM)

MBRX0.00x

SNGX0.05x

FCF Yield (TTM)

MBRX-811.4%

SNGX-180.8%

Earnings Yield (TTM)

MBRX-1040.8%

SNGX-190.0%

Dividend Yield (TTM)

MBRXN/A

SNGXN/A

Rule of 40

MBRX0.0

SNGX0.0

EV/GP/RG

MBRXN/A

SNGXN/A

Ticker research

View MBRX research View SNGX research

Metric	MBRX Moleculin Biotech Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$3M	$5M
Enterprise Value	$-4M	$-4M
Price	$0.44	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.09x
EV/Sales	0.00x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	0.86x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	131.1%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-10M
FCF (TTM)	$-25M	$-10M
EPS (TTM)	-$5.73	-$0.64
ROE (TTM)	-3539.0%	-18102.0%
ROA (TTM)	-13955.0%	-10792.0%
ROIC (TTM)	-3539.0%	-18102.0%
Financial Health
Cash	$7M	$10M
Debt	$0	$0
Net Cash/Debt	$7M	$10M
Current Ratio (TTM)	0.94x	2.77x
Quick Ratio (TTM)	0.78x	2.67x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.10	2.15
52W Performance	-96.5%	-79.9%
YTD Performance	-87.8%	-74.4%
% from 52W High	-97.2%	-81.5%
% from 52W Low	173.9%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-811.4%	-180.8%
Earnings Yield (TTM)	-1040.8%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MBRX research	View SNGX research